Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid
CLINICAL NUCLEAR MEDICINE, cilt.44, sa.9, ss.764-766, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Editöre Mektup
- Cilt numarası: 44 Sayı: 9
- Basım Tarihi: 2019
- Doi Numarası: 10.1097/rlu.0000000000002645
- Dergi Adı: CLINICAL NUCLEAR MEDICINE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.764-766
- Anahtar Kelimeler: adenoid cystic carcinoma, Ga-68-PSMA, Lu-177-PSMA, MEMBRANE ANTIGEN
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet
Özet
In vivo prostate-specific membrane antigen (PSMA) overexpression creates an opportunity for PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid. Herein, we illustrate a patient with metastatic PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid who had intense PSMA uptake on metastatic lesions, followed by radionuclide therapy with Lu-177-PSMA.